These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6188256)

  • 1. Semi-specific immunosuppression in canine kidney allograft with I131 labelled ATG.
    Corman J; Smeesters C; Giroux L; St-Louis G; Leveille M; Lavigne CM; Lamoureux J; Jean G; Daloze P
    Transplant Proc; 1982 Dec; 14(4):656-8. PubMed ID: 6188256
    [No Abstract]   [Full Text] [Related]  

  • 2. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 3. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantation.
    Fassbinder W; Bechstein PB; Stutte HJ; Scheuermann EH; Hanke P; Knöner M; Dathe G; Jonas D; Schoeppe W
    Neth J Med; 1985; 28(6):265-7. PubMed ID: 3892329
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental transplantation and histocompatibility systems in the canine species.
    Rapaport FT; Bachvaroff RJ
    Adv Vet Sci Comp Med; 1978; 22():195-219. PubMed ID: 153705
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.
    Thomas JM; Carver FM; Foil MB; Hall WR; Adams C; Fahrenbruch GB; Thomas FT
    Transplantation; 1983 Jul; 36(1):104-6. PubMed ID: 6346606
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined pancreas-kidney transplants using quadruple immunosuppression therapy: a comparison between antilymphoblast and antithymocyte globulins.
    Fasola CG; Hricik DE; Schulak JA
    Transplant Proc; 1995 Dec; 27(6):3135-6. PubMed ID: 8539880
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance and suppressor T cells.
    Brent L
    Proc Eur Dial Transplant Assoc; 1977; 14():245-50. PubMed ID: 341124
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients.
    Fuller TC; Cosimi AB; Russell PS
    Transplant Proc; 1978 Jun; 10(2):463-6. PubMed ID: 354136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preoperative immunosuppression in the kidney-transplanted dog in connection with specific antigenic pre-treatment].
    Harder F; Claudi B; Mihatsch M; Floersheim GL
    Helv Chir Acta; 1978 May; 45(1-2):161-5. PubMed ID: 350811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
    Alamartine E; Bellakoul R; Berthoux F
    Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitive monitoring of polyclonal antilymphocyte agents in renal transplantation.
    Clark KR; Taylor RM; Forsythe JL
    Clin Transpl; 1993; ():267-74. PubMed ID: 7918160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical immunosuppression with antilymphocyte globulin.
    Stiller CR
    Can Med Assoc J; 1976 Dec; 115(12):1190-1. PubMed ID: 793703
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies for kidney allograft rejection.
    Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.
    Toledo-Pereya LH; Whitten J; Baskin S; McNichol L; Thavarajah K; Lin W
    Bol Asoc Med P R; 1984 Jul; 76(7):293-6. PubMed ID: 6383417
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-day or ten-day ATG treatment for steroid-resistant rejection in kidney transplanted patients.
    Olausson M; Mjörnstedt L; Blohmé I
    Transplant Proc; 1995 Dec; 27(6):3434-5. PubMed ID: 8540037
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.